Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) is pleased to announce its participation in the 2024 Association for Vascular Access (AVA) Annual Scientific Meeting, scheduled from September 28 to 30 in Colorado. Founded in 1985, AVA is a multidisciplinary organization focused on advancing research, education, and collaboration to improve patient outcomes in vascular access. Covalon is proud to contribute to this esteemed community with evidence-based innovations.
“Our involvement in the AVA Annual Scientific Meeting underscores Covalon’s dedication to enhancing patient comfort and improving vascular access clinical care,” said Brent Ashton, Chief Executive Officer of Covalon. “Our silicone-adhesive dressings simplify the removal process compared to traditional acrylic dressings, and our vascular access line guard offers protection against gross contamination. Together, these products exemplify safety, compassion, and innovation, leading to better clinical outcomes.”
Covalon will showcase its comprehensive range of vascular access solutions at booth #523, including the latest CovaClear® IV Vascular Access Dressings. Attendees are invited to explore how these innovations support healthcare providers in delivering exceptional patient care worldwide. Covalon representatives will be available to discuss the latest advancements in vascular access technology and address any inquiries.
Covalon’s patented vascular access products include:
- VALGuard®: A transparent line guard designed to protect IV line connections and hubs from external contaminants.
- SurgiClear®: A dual antimicrobial clear silicone adhesive dressing with Chlorhexidine and Silver for protecting wound sites and wound closure devices.
- IV Clear®: A dual antimicrobial clear IV securement dressing that provides comprehensive antimicrobial protection.
- CovaClear® IV: A soft silicone adhesive clear IV dressing that shields insertion sites from contaminants, ideal for patients who either don’t require or cannot tolerate antimicrobials.
Scheduling Appointments and Additional Information
To schedule an appointment with a Covalon representative, please contact Ron Hebert, SVP Growth, at [email protected].
Conference Details
- Dates: September 28 – 30, 2024
- Location: Gaylord Rockies Resort & Convention Center, Aurora, CO, USA
- Registration: AVA Conference Registration
Healthcare providers unable to attend can learn more about Covalon’s solutions by visiting www.covalon.com or following the company on LinkedIn, Facebook, or Instagram.
About Covalon
Covalon is a patient-focused medical device company offering innovative, cost-effective solutions for advanced wound care, infection control, and medical device coatings. With a robust portfolio of patented technologies, Covalon provides gentle and compassionate options to support patients on their healing journey. The company develops products under its brand and also collaborates with other medical companies to commercialize products through development and licensing agreements. Covalon is listed on the TSX Venture Exchange under the symbol COV and trades on the OTCQX Market under the symbol CVALF.
